Cross-linked Hyaluronic Acid Gel HA Powder Description

Cross-linked Hyaluronic Acid Gel HA Powder is produced by crosslinking injection-grade sodium hyaluronate using crosslinking technology, followed by solidification, and finally presented in a fine, easy-to-handle powder form. End-product manufacturers need only three steps—reconstitution, filling, and sterilization—to prepare injectable crosslinked sodium hyaluronate gel. This significantly shortens the production cycle, reduces process complexity and contamination risk, while ensuring product sterility and stability.

Cross-linked Hyaluronic Acid Gel HA Powder Features

1. Cross-linking Technology Hyaluronic acid is naturally a linear polysaccharide and is rapidly broken down by enzymes in the body. Using cross-linking agents (such as BDDE or DVS) to connect HA molecular chains into a three-dimensional network structure forms a gel-like substance. This extends its degradation time to 6-12 months, while simultaneously enhancing its mechanical properties, making it suitable for filler augmentation or supporting joint cavities.

2. Biocompatibility Cross-linked hyaluronic acid retains the natural HA's capacity for water retention and lubrication. It integrates well with human tissues, thereby reducing the risk of rejection. Compliant products must undergo rigorous biosafety testing to ensure the absence of cytotoxicity or sensitization.

3. Safe, Vegan, Diverse Molecular Weights Our pure cross-linked hyaluronic acid gel represents a transformative innovation, positioned at the forefront of diverse applications spanning pharmaceuticals, veterinary care, orthopaedics, and aesthetic surgery. It is supplied exclusively in bulk form (MOQ: 10 kg), primarily intended for the production of dermal fillers.

Cross-linked Hyaluronic Acid Gel Powder Advantages

1. Safety

   • The preparation of crosslinked sodium hyaluronate powder undergoes strict process control and quality testing.

   • Sterile operating environment ensures high biosafety.

2. High Efficiency

   • Only three steps—reconstitution, filling, and sterilization—are required to prepare the final product.

   • Simplified process allows for customized production.

Cross-linked Hyaluronic Acid Gel Manufacturing

Cross-linked Hyaluronic Acid Gel HA Powder Specifications

1. Monophasic Cross-linked HA

• Material: Monophasic cross-linked HA gel with Lidocaine (Concentration: 20 mg/ml).
• 1 ml syringe packaging.
• CE Certificate: Pending approval.

2. Biphasic Cross-linked HA

• Material: Biphasic cross-linked gel (Concentration: 20 mg/ml).
• 1 ml syringe packaging.
• EU CE Certificate; CFDA approved.

3. Dermal Fillers

We also supply the final product in syringe form, with a volume of 1 ml (20 mg: 1 ml). The MOQ is 200 pieces. Currently, the syringe form is available only for European and Asian countries.

Cross-linked Hyaluronic Acid Gel HA Powder Applications

As a high-performance foundational biomaterial, Crosslinked Sodium Hyaluronate Powder can be used in the development of end-products for medical aesthetics, medical devices, and functional skincare that require high stability, long-lasting effects, and sterile safety.

1. Medical Aesthetic Fillers
Used for facial contouring, wrinkle filling, lip augmentation, etc., featuring long-lasting effects, safety, and biodegradability.

2. High-End Medical Devices

• Anti-adhesion gels/membranes for post-operative tissue anti-adhesion
• Wound dressings/hemostatic sponges to promote healing and absorb exudate
• Ophthalmic viscoelastic devices (OVD) for ophthalmic surgery
• Tissue engineering scaffolds for soft tissue repair or regenerative medicine

3. Functional Skincare Products

• Long-acting moisturizing serums or creams to form a hydrating film for sustained moisture retention
• Repair lyophilized powders or gels to improve skin barrier function and soothe sensitivity
• Anti-aging products extending the duration of action on the skin surface through crosslinked HA

Safety and Precautions

Adverse Reactions: Common local reactions include redness, swelling, and bruising, often related to the injection technique, typically subsiding within 1-2 weeks. In very rare cases, allergic reactions or granulomas may occur due to residual cross-linking agents; therefore, it is essential to choose qualified medical institutions and compliant products.

Contraindications

• Presence of infection or inflammation in the injection area.
• Individuals allergic to hyaluronic acid or cross-linking agents.
• Coagulation disorders, or during pregnancy and lactation (caution advised for some uses).

Duration of Effect: Depending on the degree of cross-linking, injection site, and individual metabolic differences, the effects typically last 6-12 months. Periodic touch-up injections are required to maintain results.

Comparison with Other Materials

1. Non-cross-linked Hyaluronic Acid
Primarily used for superficial hydration or joint lubrication. It is metabolized quickly (1-2 weeks) and cannot be used for filling or volumizing.

2. Synthetic Fillers (e.g., Silicone, Poly-L-lactic Acid)
Synthetic materials offer longer-lasting results but carry a higher risk of complications and a greater tendency to feel like a foreign substance. Cross-linked HA is biodegradable, offering a higher safety profile.